Evidence map›Paper›PMID 37237637›Full record

ArticleBioengineering (Basel, Switzerland)2023

Tailoring the Microarchitectures of 3D Printed Bone-like Scaffolds for Tissue Engineering Applications.

Eleonora Zenobi, Miriam Merco, Federico Mochi, Jacopo Ruspi, Raffaella Pecci, Rodolfo Marchese, Annalisa Convertino, Antonella Lisi, Costantino Del Gaudio, Mario Ledda

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eleonora ZenobiHypatia Research Consortium, Via del Politecnico snc, 00133 Rome, Italy.
Miriam MercoInstitute of Translational Pharmacology, National Research Council, Via Fosso del Cavaliere 100, 00133 Rome, Italy.
Federico MochiHypatia Research Consortium, Via del Politecnico snc, 00133 Rome, Italy.ORCID 0000-0003-4928-7893
Jacopo RuspiBiomedical Engineering, Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Piazzale Aldo Moro, 00184 Rome, Italy.ORCID 0009-0002-3677-510X
Raffaella PecciNational Centre for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Viale Regina Elena, 00161 Rome, Italy.ORCID 0000-0002-6500-9124
Rodolfo MarcheseDepartment of Clinical Pathology, Fatebenefratelli S. Peter Hospital, Via Cassia, 00189 Rome, Italy.
Annalisa ConvertinoInstitute for Microelectronics and Microsystems, National Research Council, Via Fosso del Cavaliere 100, 00133 Rome, Italy.ORCID 0000-0002-9426-8352
Antonella LisiInstitute of Translational Pharmacology, National Research Council, Via Fosso del Cavaliere 100, 00133 Rome, Italy.ORCID 0000-0002-5465-9500
Costantino Del GaudioItalian Space Agency, Via del Politecnico snc, 00133 Rome, Italy.
Mario LeddaInstitute of Translational Pharmacology, National Research Council, Via Fosso del Cavaliere 100, 00133 Rome, Italy.ORCID 0000-0002-0349-8938

Funding

POR FESR LAZIO 2014-2020-Gruppi di Ricerca 2020. Dispositivi biomimetici realizzati mediante stampa 3D per il trattamento di patologie del sistema scheletrico (BioBone3D) A0375-2020-36493
6 · The paper itself

Abstract

Material extrusion (MEX), commonly referred to as fused deposition modeling (FDM) or fused filament fabrication (FFF), is a versatile and cost-effective technique to fabricate suitable scaffolds for tissue engineering. Driven by a computer-aided design input, specific patterns can be easily collected in an extremely reproducible and repeatable process. Referring to possible skeletal affections, 3D-printed scaffolds can support tissue regeneration of large bone defects with complex geometries, an open major clinical challenge. In this study, polylactic acid scaffolds were printed resembling trabecular bone microarchitecture in order to deal with morphologically biomimetic features to potentially enhance the biological outcome. Three models with different pore sizes (i.e., 500, 600, and 700 µm) were prepared and evaluated by means of micro-computed tomography. The biological assessment was carried out seeding SAOS-2 cells, a bone-like cell model, on the scaffolds, which showed excellent biocompatibility, bioactivity, and osteoinductivity. The model with larger pores, characterized by improved osteoconductive properties and protein adsorption rate, was further investigated as a potential platform for bone-tissue engineering, evaluating the paracrine activity of human mesenchymal stem cells. The reported findings demonstrate that the designed microarchitecture, better mimicking the natural bone extracellular matrix, favors a greater bioactivity and can be thus regarded as an interesting option for bone-tissue engineering.

Indexed as

3D printingbiomimetic bone scaffoldshMSC evaluationin vitro SAOS-2micro-CTtissue engineering

Identifiers

PMID37237637
PMCPMC10215619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.